STRATEGIC PARTNERS 

Partnering with EKR

EKR Therapeutics is dedicated to improving the lives of cancer patients by actively and continually searching for and commercializing products that respond to the need for improving their quality of life. We believe that expertise is specialty pharmaceuticals is born out of maximizing the potential for products in a focused therapeutic area, and we embrace the potential to build effective partnerships with companies which believe their products have more potential in the hands of a focused company like EKR.

EKR offers the commercialization expertise of its management team, led by executives with the experience of having previous success in building specialty pharmaceutical businesses. Beyond the product we are committed to forming strategic alliances that create value for both partners and to enhance the choice of therapies available to fulfill the unmet needs of patients.

If you have an opportunity that may fit with our company, you can be sure it will receive a prompt yet comprehensive evaluation. We have licensing experts that understand the importance of your goals in partnering and appreciate the importance of an expedited decision process. We are flexible in our approach, entertaining a multitude of potential deal structures.

Helsinn Healthcare S.A. is a privately owned pharmaceutical group with headquarters in Switzerland and is the worldwide licensor of Gelclair^®, Helsinn's core business is the licensing of pharmaceuticals in niche therapeutic areas.